查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968538

犬類整形外科市場－全球產業規模、佔有率、趨勢、機會和預測：按產品、應用、最終用途、地區和競爭對手分類，2021-2031年

Canine Orthopedics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球犬類整形外科市場預計將從 2025 年的 2.6253 億美元成長到 2031 年的 4.3474 億美元，複合年成長率達到 8.77%。

此領域涵蓋專門用於治療犬類肌肉骨骼損傷和退化性疾病的醫療植入、器械和輔助設備的製造和供應。推動該行業發展的主要動力是寵物日益人性化，以及寵物飼養率的不斷上升，這促使飼主尋求針對骨關節炎和十字韌帶斷裂等疾病的先進醫療服務。為了滿足不斷成長的患者群體，美國獸醫協會 (AVMA) 預計，到 2024 年，美國犬隻數量將達到 8,970 萬隻，這一數字直接推動了對專業獸醫整形外科產品和服務的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 2.6253億美元
市場規模：2031年 4.3474億美元
複合年成長率：2026-2031年 8.77%
成長最快的細分市場 植入
最大的市場 北美洲

儘管有這些正面趨勢，但市場仍存在一個主要障礙：複雜整形外科手術的高昂費用。全髖關節置換術和骨折修復等手術需要昂貴的材料和高技能獸醫專家的知識，這對寵物飼主來說是一筆不小的經濟負擔。這種經濟障礙往往限制了未投保寵物獲得高品質獸醫服務的機會，並阻礙了市場在可支配收入低、獸醫基礎設施落後的發展中地區的滲透。

市場促進因素

犬類肌肉骨骼疾病和肥胖症的日益普遍是推動市場擴張的主要動力，也因此對整形外科干預措施的需求持續成長。犬類體重過重會顯著加速關節劣化，增加骨關節炎和十字韌帶損傷的發生率，這些疾病需要透過手術修復或植入進行長期治療。體重與整形外科健康之間的關聯在臨床統計數據中日益凸顯。根據寵物肥胖預防協會於2025年4月發布的《2024年寵物肥胖與營養意見調查》，35%的犬飼主認為他們的寵物超重或肥胖，較前一年的17%顯著上升。隨著高風險犬群的不斷擴大，獸醫在應對與體重相關的併發症所帶來的身體影響時，對從診斷工具到先進手術植入等綜合整形外科解決方案的需求也日益成長。

同時，寵物健康保險投保率的不斷提高，減輕了昂貴的整形外科手術帶來的經濟負擔，並擴大了高品質醫療服務的覆蓋範圍。隨著保險覆蓋範圍的擴大，飼主越來越願意核准諸如全髖關節置換術和骨折修復等昂貴的治療，而這些治療費用在他們看來可能難以負擔。根據北美寵物健康保險協會（NAPHIA）於2025年4月發布的《2025年產業趨勢報告》，截至2024年底，美國寵物保險保費總收入約47億美元。在獸醫費用持續上漲的背景下，這層財務保障至關重要。 Synchrony公司2025年的預測顯示，一隻狗的終身醫療費用將從22,125美元增加到60,602美元，而保險業在將潛在需求轉化為實際手術收入方面發揮著至關重要的作用。

市場挑戰

複雜整形外科手術的高昂費用是全球犬類整形外科市場發展的主要障礙。諸如全髖關節置換術和十字韌帶修復等手術需要昂貴的醫療植入和專業獸醫外科醫生的精湛技藝。因此，這些手術的費用超出了許多寵物飼主的可支配收入，迫使他們選擇保守治療或非手術治療。在極端情況下，甚至會選擇安樂死。這種經濟限制直接減少了植入和器械的使用，阻礙了市場的獲利能力，並限制了先進技術的推廣應用。

此外，由於寵物健康保險普及率仍然很低，市場嚴重依賴自費支付。缺乏經濟保障加劇了飼主在獲得可負擔醫療服務方面的不平等，尤其是在面臨意外高額醫療費用時。根據北美寵物健康保險協會（NAPHIA）的數據，到2024年，北美地區投保寵物的總數將達到703萬隻。這項數據表明，絕大多數寵物仍然沒有保險，迫使大多數飼主獨自承擔高昂的整形外科治療費用，並極大地限制了外科手術治療方案的潛在市場。

市場趨勢

再生醫學與整形外科手術的融合正將市場重心從簡單的症狀管理轉向生物修復。獸醫外科醫生擴大將幹細胞療法和富血小板血漿（PRP）療法與外科手術相結合，以促進組織癒合並延緩骨關節炎的進展。隨著生技公司吸引大量投資用於開發標準化、即用型生物製品，這種方法正逐漸具備商業性可行性。例如，在2025年6月題為「Gallant完成1800萬美元B輪資金籌措，將推出可上市的寵物幹細胞療法」的新聞稿中，Gallant宣布已獲得1800萬美元資金，用於推進其同種異體幹細胞產品線獲得FDA有條件核准。這表明，治療方向正從單純掩蓋疼痛轉向能夠治療關節退化根本原因的可擴展治療方法。

同時，專業的術後復健技術的推廣應用，正將結構化的復健通訊協定確立為整形外科治療的關鍵要素。獸醫界普遍認為，專業的復健治療能顯著改善手術效果，因此對運動醫學專家和特定復健計畫的需求日益成長。此外，用於完善競技犬復健技術的臨床研究經費的增加也進一步推動了這項進展。根據美國犬業俱樂部犬類健康基金會於2025年8月發布的《2024年影響報告》，該基金會策略性地投資了320萬美元，用於42項研究津貼，其中包括對運動醫學和復健專家培訓計畫的專項支持。這項工作對於檢驗實證策略至重要，能夠確保複雜的整形外科修復手術能帶來最佳的長期功能活動能力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球犬類整形外科市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（植入、器械）
    • 依應用領域（TPLO、TTA、關節重建、創傷、其他）
    • 依最終用途（醫院/診所、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美犬類整形外科市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲犬類整形外科市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區犬類整形外科市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲犬類整形外科市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美犬類整形外科市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球犬類整形外科市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • B. Braun SE
  • Movora
  • Steris Plc
  • Johnson & Johnson Services, Inc.
  • Cencora, Inc.
  • Arthrex, Inc.
  • Orthomed（UK）Ltd
  • Veterinary Instrumentation Ltd
  • Fusion Implants
  • Narang Medical Limited

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23986

The Global Canine Orthopedics Market is projected to expand from USD 262.53 Million in 2025 to USD 434.74 Million by 2031, achieving a compound annual growth rate (CAGR) of 8.77%. This sector encompasses the production and supply of medical implants, instruments, and supportive devices specifically engineered to manage musculoskeletal injuries and degenerative diseases in dogs. A major force propelling this industry is the growing trend of pet humanization alongside increasing pet ownership, which encourages owners to pursue sophisticated medical treatments for conditions like osteoarthritis and cruciate ligament ruptures. Highlighting this expanding patient base, the American Veterinary Medical Association estimated the United States dog population at 89.7 million in 2024, a figure that directly underpins the demand for specialized veterinary orthopedic products and services.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 262.53 Million
Market Size 2031USD 434.74 Million
CAGR 2026-20318.77%
Fastest Growing SegmentImplants
Largest MarketNorth America

Despite these favorable trends, the market faces a substantial obstacle regarding the significant expense of complex orthopedic surgeries. Procedures such as total hip replacements and fracture repairs necessitate costly materials and the expertise of highly skilled veterinary specialists, creating a heavy financial load for pet owners. This affordability barrier frequently restricts access to premium veterinary care for uninsured pets and hampers market penetration in developing areas where disposable income is lower and veterinary healthcare infrastructure is not yet fully established.

Market Driver

The escalating prevalence of canine musculoskeletal disorders and obesity serves as a primary engine for market expansion, generating consistent demand for orthopedic interventions. Excess body weight in dogs markedly hastens joint deterioration, resulting in higher rates of osteoarthritis and cruciate ligament injuries that necessitate surgical repair or long-term management via implants. The correlation between weight and orthopedic health is increasingly apparent in clinical statistics; according to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners identified their pets as overweight or having obesity, a significant rise from 17% the previous year. This increase in the at-risk population drives the need for comprehensive orthopedic solutions, ranging from diagnostic tools to advanced surgical implants, as veterinarians manage the physical consequences of weight-related comorbidities.

In parallel, the growing uptake of pet health insurance policies is alleviating the financial hurdles linked to expensive orthopedic procedures, thereby widening patient access to high-quality care. As coverage becomes more prevalent, owners are more inclined to authorize costly treatments like total hip replacements or fracture repairs that might otherwise be financially out of reach. According to the North American Pet Health Insurance Association's '2025 State of the Industry Report' from April 2025, total pet insurance premium volume in the United States hit roughly $4.7 billion by the end of 2024. This financial safety net is crucial given the escalating costs of veterinary medicine, with Synchrony estimating in 2025 that the lifetime cost of dog care has increased to between $22,125 and $60,602, making the insurance sector a key facilitator in converting potential demand into realized surgical revenue.

Market Challenge

The significant expense attached to complex orthopedic surgeries acts as a major impediment to the growth of the Global Canine Orthopedics Market. Interventions such as total hip replacements and cruciate ligament repairs require high-cost medical-grade implants and the skills of specialized veterinary surgeons. As a result, the cost of these procedures frequently surpasses the disposable income of many pet owners, compelling them to choose conservative, non-surgical management or, in extreme situations, economic euthanasia. This economic limitation directly decreases the volume of implants and instruments used, thereby hindering market revenue potential and restricting the uptake of advanced technologies.

Additionally, the market depends heavily on out-of-pocket payments because pet health insurance remains relatively uncommon. The absence of financial safety nets worsens the affordability gap, especially when owners confront sudden, substantial medical bills. According to the North American Pet Health Insurance Association, the total number of insured pets in North America reached 7.03 million in 2024. This statistic suggests that the vast majority of the pet population is still uninsured, leaving most owners solely accountable for the heavy financial load of premium orthopedic care and significantly limiting the addressable market for surgical solutions.

Market Trends

The integration of Regenerative Medicine Therapies with Orthopedic Procedures is transitioning the market's focus from simple symptom management to biological restoration. Veterinary surgeons are increasingly combining stem cell therapies and platelet-rich plasma with surgical interventions to hasten tissue healing and slow the progression of osteoarthritis. This method is becoming commercially viable as biotechnology companies attract significant investment to create standardized, off-the-shelf biological products. For instance, Gallant Therapeutics announced in a June 2025 press release, 'Gallant Closes $18 Million Series B to Bring Ready-to-Use Stem Cell Therapies for Pets to Market,' that it secured $18 million to further the conditional FDA approval of its allogeneic stem cell pipeline, signaling a shift toward scalable therapeutics that treat the root causes of joint degeneration rather than just masking pain.

Concurrently, the expansion of Specialized Post-Operative Physical Rehabilitation Modalities is solidifying structured recovery protocols as a vital element of orthopedic care. The veterinary community increasingly acknowledges that surgical results are vastly improved when accompanied by professional rehabilitation, fueling demand for sports medicine specialists and specific recovery programs. This development is bolstered by growing funding for clinical research aimed at perfecting rehabilitation techniques for canine athletes. As reported by the American Kennel Club Canine Health Foundation in its August 2025 '2024 Impact Report,' the organization strategically invested $3.2 million across 42 research grants, including specific support for sports medicine and rehabilitation residency programs, which is essential for validating evidence-based strategies to ensure complex orthopedic repairs lead to optimal long-term functional mobility.

Key Market Players

  • B. Braun SE
  • Movora
  • Steris Plc
  • Johnson & Johnson Services, Inc.
  • Cencora, Inc.
  • Arthrex, Inc.
  • Orthomed (UK) Ltd
  • Veterinary Instrumentation Ltd
  • Fusion Implants
  • Narang Medical Limited

Report Scope

In this report, the Global Canine Orthopedics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Canine Orthopedics Market, By Product

  • Implants
  • Instruments

Canine Orthopedics Market, By Application

  • TPLO
  • TTA
  • Joint Replacement
  • Trauma
  • Others

Canine Orthopedics Market, By End-use

  • Hospitals & Clinics
  • Others

Canine Orthopedics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Canine Orthopedics Market.

Available Customizations:

Global Canine Orthopedics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Canine Orthopedics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Implants, Instruments)
    • 5.2.2. By Application (TPLO, TTA, Joint Replacement, Trauma, Others)
    • 5.2.3. By End-use (Hospitals & Clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Canine Orthopedics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Canine Orthopedics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Canine Orthopedics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Canine Orthopedics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use

7. Europe Canine Orthopedics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Canine Orthopedics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Canine Orthopedics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Canine Orthopedics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Canine Orthopedics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Canine Orthopedics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-use

8. Asia Pacific Canine Orthopedics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Canine Orthopedics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Canine Orthopedics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Canine Orthopedics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Canine Orthopedics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Canine Orthopedics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Canine Orthopedics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Canine Orthopedics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Canine Orthopedics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Canine Orthopedics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. South America Canine Orthopedics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Canine Orthopedics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Canine Orthopedics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Canine Orthopedics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Canine Orthopedics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. B. Braun SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Movora
  • 15.3. Steris Plc
  • 15.4. Johnson & Johnson Services, Inc.
  • 15.5. Cencora, Inc.
  • 15.6. Arthrex, Inc.
  • 15.7. Orthomed (UK) Ltd
  • 15.8. Veterinary Instrumentation Ltd
  • 15.9. Fusion Implants
  • 15.10. Narang Medical Limited

16. Strategic Recommendations

17. About Us & Disclaimer